Reinventing Skin Science


Delivering effective pharmaceutical solutions requires a team of visionaries who are committed to achieving success. Rich in experience, brilliance and tenacity the leadership team at Verrica is tirelessly dedicated to developing innovative therapies in medical dermatology.

BRIAN DAVIS, Chief Financial Officer

Brian Davis has served as our Chief Financial Officer since October 2019. Prior to joining our company, Mr. Davis was the Chief Financial Officer of Strongbridge Biopharma, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Previously, he held the title of Senior Vice President and CFO at Tengion, a public, clinical-stage biotechnology company. Mr. Davis also held a similar role at Neose Technologies. Mr. Davis has extensive expertise in fundraising, having raised over $500 million in public and private equity financings and over $140 million in debt financings, as well as in shareholder relations, financial strategy, and SEC accounting, reporting, and compliance. Mr. Davis holds an MBA from The Wharton School, University of Pennsylvania, and a BS in Accounting from Trenton State College.